Alchornea cordifolia is a medicinal plant, whose ethanolic and methanolic extracts have shown antioxidant activity which could confer hepatoprotective effect, knowing that liver cells are attacked by free radicals. The hepatoprotective effect of these extracts has been demonstrated in models of hepatotoxicity induced by paracetamol high doses in animals. However, anti-tubercular drugs at the usual dose present hepatotoxicity risk. Could Alchornea cordifolia help to limit hepatotoxicity induced by anti-tubercular drugs? This work aimed to evaluate the antioxidant activity and the hepatoprotective effect of an aqueous extract of A. cordifolia leaves (AEAC). The antioxidant activity of A. cordifolia leaves was studied in vitro by 1,1-diphenyl-2-picrylhydrazyl (DPPH) free radicals scavenging assay and by the iron reduction ability. A phytochemical screening was carried out to identify the chemical groups that could be responsible for this activity. The hepatoprotective effect was demonstrated in a model of hepatotoxicity induced by isoniazid and rifampicin in rats. Two hours after induction of hepatotoxicity, the animals were orally administered the AEAC at 200 mg/kg, 400 mg/kg, 800 mg/kg for 10 consecutive days. A blood sample was taken on the 11 th day for the evaluation of transaminases, markers of hepatic cytolysis. A totally of 96 rats were used in this study. AEAC showed dose-dependent antioxidant activity. Phytochemical screening revealed the presence of flavonoids, tannins and alkaloids. Administrated alone, aqueous extract of A. cordifolia leaves didn't modificate the transaminases, isoniazid and the isoniazid + rifampicin combination resulted in increasing transaminases (ALT and AST) by more than 48%. AEAC at 800 mg/kg reduced AST and ALT levels by more than 45%. AEAC at 200 mg/kg and 400 mg/kg decreased ALT more than 40%. Knowing that antioxidant activity protects liver, the AEAC may by its antioxidant activity, contribute to protect against the hepatotoxicity induced by an-
Introduction
Herbal treatments are becoming increasingly important within populations. These plants are mostly endowed with antioxidant properties able to inhibit free radicals formation and to oppose macromolecules oxidation [1] . Free radicals have been implicated in a number of pathological processes, such as asthma, cancer, cardiovascular disease, cataracts, diabetes, inflammatory diseases, liver diseases and degenerative diseases [2] . Antioxidants can inhibit or retard the oxidation of an oxidizable substrate in a chain reaction [3] . The properties of these plants used in traditional medicine were attributed mainly to the presence of polyphenols [4] .
Several works of our department have dealt with Alchornea cordifolia [5] [6] . A. cordifolia is a very popular herb in African traditional medicine for its many
properties. Many studies have demonstrated its antioxidant properties [7] [8] .
This antioxidant activity is manifested by free radical scavenging [9] [10] , which can confer a hepatoprotective effect [7] [8] [11] . The liver is indeed the main organ involved in metabolism and detoxification for the excretion of various endogenous and exogenous substances. However, liver cells are prone to be attacked and necrotic by free radicals [12] .
The antioxidant properties of a methanolic extract and an ethanolic extract of A. cordifolia have been studied [7] [8] . The hepatoprotective properties of these extracts have also been demonstrated against high-dose paracetamol-induced hepatotoxicity in an animal model [7] [11] .
However, the antioxidant properties and the hepatoprotective effect of the aqueous extract, which is the most usual form in traditional human medicine, seem to have been little studied. In addition, the hepatoprotective effect of A. cordifolia has not been found in the literature against the hepatotoxicity of anti-tubercular drugs. Antitubercular drugs (isoniazid (INH) and rifampicin (RIF)) are responsible for many adverse effects in liver at the usual doses [13] [14] . These effects are cytolytic and result in an increase in serum transaminases [15] [16] . Aouam et al. (2007) [17] reported hepatic disorders in 10% to 20% of users in Tunisia with INH at therapeutic dose, when Blumberg et al. (2003) [13] reported disturbances of hepatic markers in 0.5% to 2% of patients in the USA. When the RIF was associated with the INH, this disturbance affected more patients [17] , which was 2.5% to 6% of the patients according to Blumberg et al. (2003) [13] .
This work aimed to evaluate the antioxidant properties and the hepatoprotective effect of an aqueous extract of A. cordifolia leaves in order to overcome the 
Material and Method

Plant material
The plant material consisted of leaves of Alchornea cordifolia (Schum. and Thonn.) collected at Yakasse-Mé (in the city of Adzopé about 75 km from Abidjan, Ivory Coast). Voucher samples (AC 2016) are kept in the Pharmacology laboratory. The leaves were authenticated at the National Floristic Center of Abidjan, affiliated to Université Félix Houphouët Boigny (Abidjan). These leaves were air-dried in the laboratory at 18˚C.
Extraction method
Fine powder of dried leaves (100 g) was macerated for 24 h at room temperature in 1 L of distilled water. The resulting filtrate was dried in a MEMMERT oven at 60˚ for 72 h. The obtained dry extract (aqueous extract of Alchornea cordifolia:
AEAC) was conserved at 4˚C; and aliquots of dry powder were used for pharmacological studies after being suspended in physiological saline.
Animal material
The animal material consisted of rats, Rattus norvegicus, Wistar strain weighing between 150 g and 220 g. 96 rats were used for 3 series of studies. They were ob- Food and water and are given Ad libitium. Before the beginning of the experiment, they were subjected to fasting for 12 hours with free access to water.
Chemicals materials used
In this study, we used isotonic saline solution 0.9%, ether (Gifrer), distilled water, 
Chemical analysis
Screening for different chemical groups was done using the method as described in the works of Békro et al. (1973) [19] , Ronchetti and Russo (1971) [20] and Wagner (1983) [21] . 1) The rats in lot 1 (negative control) received saline solution by gavage;
2) The rats in lot 2 received AEAC at 200 mg/kg/day by gavage;
3) The rats in lot 3 received AEAC at 400 mg/kg/day by gavage;
4) The rats in lot 4received AEAC at 800 mg/kg/day by gavage.
Hepatoprotective effect against INH-induced hepatotoxicity:
Rats of both sexes were divided into 6 batches of 6 rats each and were treated for 10 days as follows:
1) The rats in lot 1 (negative control) received saline solution by gavage;
2) The rats in lot 2 received INH (100 mg/kg/day) by gavage;
3) The rats in lots 3, 4 and 5 received AEAC (200, 400 and 800 mg/kg) orally 2 hours after administration of INH (100 mg/kg/day);
4) The rats in lot 6 (positive control) received silymarin (100 mg/kg/day) orally, 2 h after administration of INH (100 mg/kg/day).
Hepatoprotective effect against INH+RIF-induced hepatotoxicity:
2) The rats in lot 2 received INH (100 mg/kg/day) + RIF (100 mg/kg/day) by gavage;
3) The rats in lots 3, 4 and 5 received AEAC (200, 400 and 800 mg/kg/day) orally 2 hours after administration of INH (100 mg/kg/day) + RIF (100 mg/kg/day);
4) The rats in lot 6 (positive control) received silymarin (100 mg/kg/day) orally, 2 h after administration of INH (100 mg/kg/day) + RIF (100 mg/kg/day).
Liver Biochemical Indices measured
At the end of the 10 days of treatment, a blood sample was taken the 11 th day by cardiac puncture for the determination of markers of hepatotoxicity. They were alanine aminotransferase (ALT) and aspartate aminotransferase (AST) [27] , using standard kits.
Statistical analysis
The results were expressed as mean ± SD. Statistical analysis used the Wilcoxon test. The difference between the mean values was considered significant if p < 0.05.
Results
Extraction yield
Extraction with distilled water (AEAC) gave 8.34 g of dry residue, a yield of 8.34%.
Result on measurement of reducing power Figure 1 shows the results of iron reductive ability by AEAC and trolox. The AEAC has a reducing power which increases proportionally with the concentration. The same is true of the trolox. However, the AEAC activity is statistically inferior to that of the trolox. 
Measurement of anti-radical activity: DPPH
The results of the anti-radical activity of AEAC and vitamin C are recorded in Figure 2 . The AEAC shows an antiradical activity which increases with the concentration as well as the ascorbic acid. The anti-radical activity of the AEAC remains statistically comparable to that of the vitamin C at 100 μg/mL.
Phytochemical characterization test
The characterization tests of the large phytochemical groups carried out on the AEAC revealed the presence of flavonoids, tannins and alkaloids, and an absence of saponosides.
Results of the EAAC effect on transaminases
The effect of AEAC alone was evaluated on serum transaminases and the var- 
Discussion
This study aimed to evaluate the in vitro antioxidant activity of an aqueous extract of A. cordifolia leaves and its hepatoprotective effect in vivo in rats. The antioxidant activity of the aqueous extract of A. cordifolia leaves was evaluated by iron reductive ability [28] and free radical scavenging [24] .
The presence of reducing agents in an extract causes the reduction of ferric iron (Fe 3+ ) to ferrous iron (Fe 2+ ). Antioxidants are considered oxidant reducing agents and inactivators [29] . Other studies have also shown that the reducing power of a compound could serve as a significant indicator of its potential antioxidant activity [30] [31].
DPPH radical involves a hydrogen atom transfer process [32] . The antiradical activity results in a donation of electrons or protons reducing the hydrazyl radical form of DPPH in non-radical form hydrazine. All substances with free radical scavenging are known as antioxidants [33] . The aqueous extract of A. cordifolia would trap the DPPH radical and thus could have antioxidant activity.
There is a potential antioxidant activity of the aqueous extract of A. cordifolia.
This antioxidant activity is statistically less than that of trolox and vitamin C.
Osadebe et al. (2012) [8] showed comparable antioxidant activity of the methanolic extract of A. cordifolia to that of vitamin C in their studies. Other studies on an ethanolic extract of A. cordifolia showed better antioxidant activity than vitamin E [7] .
Comparative study of the chemical constituents revealed the presence of alkaloids, saponins, tannins, and flavonoids both in the methanolic extract [8] and in the ethanol extract [7] , while the aqueous extract contained alkaloids, tannins and flavonoids. It emerges almost a similarity of the major chemical groups likely to be responsible for antioxidant activity. Indeed, Manga et al. (2004) [34] This antioxidant activity of the aqueous extract of A. cordifolia could confer a protective effect of the liver which is subject to attack and necrosis by free radicals [12] .
The study of the hepatoprotective effect of the aqueous extract of A. cordifolia was demonstrated using high-dose anti-tubercular drugs for 10 days in different combinations to induce hepatotoxicity in laboratory animals [25] [26]. They produce various categories of lesions in the liver, including centrilobular necrosis, hepatic cell degeneration [37] . These lesions resulted in an increase in serum transaminases [15] [16] as observed in hepatotoxic rats. Isoniazid alone and the Isoniazid + Rifampicin combination resulted in a significant increase in ALT and AST levels. ALT and AST are two well-known diagnostic indicators of liver damage. In liver damage with hepatocellular lesions and parenchymal cell necrosis, these marker enzymes are released from damaged tissues and their levels increase in blood flow [38] . These are two hepatic enzymes linked to the subcellular functions of the mitochondria [39] .
Administration of the aqueous extract of A. cordifolia at 200 mg/kg, 400 mg/kg and 800 mg/kg significantly decreased disturbed ALT values. The extract at 800 mg/kg decreased the AST. The extract at 800 mg/kg had an effect on ALT and AST which was superposable to that of silymarin, a hepatoprotectant used as a reference in this study [18] . The lower doses of the extract were active only on ALT, which is more specific to the liver. Nonetheless, the AST values were reduced, although not significant, at these doses (p > 0.05).
This ability of the aqueous extract of A. cordifolia to lower these values may suggest hepatoprotective activity of A. cordifolia leaves, especially at 800 mg/kg. This activity would be manifested by stabilization of the hepatic membrane and regeneration of the hepatocytes. The extract would also prevent the release of hepatic enzymes at the level of the blood stream by a reduction of the tissue lesions [40] [41] .
This hepatoprotective activity of an ethanol extract and a methanolic extract of A. cordifolia leaves has already been demonstrated in rats against hepatotoxicity induced by paracetamol at high levels [7] [11] [42] and carbon tetrachloride [8] . The results of our work on the aqueous extract of A. cordifolia confirm this property of A. cordifolia. Moreover, at all the doses used, the aqueous extract of A. cordifolia was not hepatotoxic itself, in contrast to the methanolic extract which was hepatotoxic at doses greater than or equal to 800 mg/kg in of male rats [43] . More polar solvents, in addition to extracting more active ingredients for better efficiency, would also extract more toxic principles. The aqueous ex- 
Conclusion
The present study demonstrated that the aqueous extract of A. cordifolia leaves could have antioxidant activity and confer significant protection against the hepatotoxic effects of anti-tubercular drugs.
